We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna’s COVID-19 Vaccine Effective After Six Months, Phase 3 Trial Data Shows
Moderna’s COVID-19 Vaccine Effective After Six Months, Phase 3 Trial Data Shows
New data from Moderna’s phase 3 COVID-19 vaccine trial have shown that the U.S. drugmaker’s two-dose inoculation remains highly effective against the virus six months after the second shot, including for severe infection, the company said Tuesday.